"Herpesvirus 4, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies.
| Descriptor ID |
D004854
|
| MeSH Number(s) |
B04.280.210.400.500.450 B04.280.382.400.500.400 B04.613.204.500.500.400
|
| Concept/Terms |
Herpesvirus 4, Human- Herpesvirus 4, Human
- Burkitt Lymphoma Virus
- Lymphoma Virus, Burkitt
- Burkitt's Lymphoma Virus
- Burkitts Lymphoma Virus
- E-B Virus
- E B Virus
- E-B Viruses
- Infectious Mononucleosis Virus
- Infectious Mononucleosis Viruses
- Mononucleosis Virus, Infectious
- Mononucleosis Viruses, Infectious
- Epstein-Barr Virus
- Epstein Barr Virus
- Herpesvirus 4 (gamma), Human
- HHV-4
- Human Herpesvirus 4
- Burkitt Herpesvirus
- Herpesvirus, Burkitt
- EBV
|
Below are MeSH descriptors whose meaning is more general than "Herpesvirus 4, Human".
Below are MeSH descriptors whose meaning is more specific than "Herpesvirus 4, Human".
This graph shows the total number of publications written about "Herpesvirus 4, Human" by people in this website by year, and whether "Herpesvirus 4, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 |
| 1995 | 1 | 0 | 1 |
| 1996 | 3 | 0 | 3 |
| 1997 | 2 | 2 | 4 |
| 1998 | 1 | 1 | 2 |
| 1999 | 3 | 2 | 5 |
| 2000 | 3 | 1 | 4 |
| 2001 | 1 | 3 | 4 |
| 2002 | 2 | 1 | 3 |
| 2003 | 3 | 0 | 3 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 2 | 3 |
| 2006 | 2 | 1 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 1 | 3 |
| 2012 | 2 | 1 | 3 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 2 | 3 |
| 2015 | 2 | 2 | 4 |
| 2016 | 0 | 1 | 1 |
| 2018 | 2 | 0 | 2 |
| 2019 | 0 | 2 | 2 |
| 2020 | 1 | 2 | 3 |
| 2021 | 2 | 1 | 3 |
| 2022 | 2 | 2 | 4 |
| 2023 | 1 | 2 | 3 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Herpesvirus 4, Human" by people in Profiles.
-
A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations. Int J Cancer. 2024 Oct 15; 155(8):1476-1486.
-
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol. Blood Adv. 2024 06 25; 8(12):3001-3012.
-
Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer. mBio. 2023 Oct 31; 14(5):e0039623.
-
Epstein-Barr Virus DNA Screening in Asymptomatic People without Known Nasopharyngeal Cancer. NEJM Evid. 2023 Jul; 2(7):EVIDe2300077.
-
EBV-positive inflammatory FDC/FRC tumor: no longer pseudo or sarcoma! Blood. 2023 02 23; 141(8):961.
-
Epstein-Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments. Int J Mol Sci. 2022 Nov 19; 23(22).
-
Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience. Front Immunol. 2022; 13:864545.
-
The nuclear lamina binds the EBV genome during latency and regulates viral gene expression. PLoS Pathog. 2022 04; 18(4):e1010400.
-
The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity. Nat Commun. 2022 01 17; 13(1):187.
-
Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma. Sci Rep. 2021 12 08; 11(1):23664.